Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 671-680

  Hermsmeyer, Kent ^a   Miyagawa, Koichi ^a   Kelley, Stephen T ^a   Rösch, Josef ^b   Hall, Arthur S ^b   Axthelm, Michael K ^a   Greenberg, Barry ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN; ENDOTHELIN 1; MIBEFRADIL; NITRENDIPINE; SEROTONIN;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY CONSTRICTION; FEMALE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; INTRACARDIAC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; VASOSPASM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; CORONARY VESSELS; FEMALE; MACACA MULATTA; MALE; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0031056966     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00524-4     Document Type: Article

References (43)

1. Maseri A, Pesola A, Marzilli M, et al. Coronary vasospasm in angina pectoris. Lancet 1977;1:713-7.
2. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. Circulation 1990;81:1983-90.
3. Braunwald E. Coronary artery spasm as a cause of myocardial ischemia. J Lab Clin Med 1981;97:299-312.
4. Marcus ML. Effects of coronary spasm on the coronary circulation. In: ML Marcus, editor. The Coronary Circulation in Health and Disease. New York: McGraw-Hill, 1983:270-84.
5. Kaski JC, Maseri A, Vejar M, Crea F, Hackett D, Halson P. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol 1989;14:1456-63.
6. Selwyn AP, Braunwald E. Ischemic heart disease. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill, 1994:1077-85.
7. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981;304:685-91.
8. 2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. Circulation 1987;76:952-9.
9. 2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries. J Am Coll Cardiol 1989;13:755-63.
10. Willerson JT. Conversion from chronic to acute coronary heart disease syndromes: role of platelets and platelet products. Texas Heart Inst J 1995;22:13-9.
11. Eidt JF, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Thromboxane A, and serotonin mediate coronary blood flow reductions in unsedated dogs. Am J Physiol 1989;257:H873-82.
12. Golino P, Piscione F, Willerson JT, et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991;324:641-8.
13. Bertrand ME, La Blanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306.
14. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994;90:5-11.
15. Hillis LD, Braunwald E. Coronary-artery spasm. New Engl J Med 1978;299: 695-702.
16. Maseri A. Variant angina and coronary vasospasm: clues to a broader understanding of angina pectoris. Cardiovasc Med 1979;4:647-67.
17. Kaski JC, Crea F, Meran D, et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986;74: 1255-65.
18. Kalsner S. Coronary artery spasm: multiple causes and multiple roles in heart disease. Biochem Pharmacol 1995;49:859-71.
19. Egashira K, Tomoike H, Hayashi Y, Yamada A, Nakamura M, Takeshita A. Mechanism of ergonovine-induced hyperconstriction of the large epicardial coronary artery in conscious dogs a month after arterial surgery. Circ Res 1992;71:435-42.
20. Benzuly K, Padgett RC, Kaul S, Piegors DJ, Armstrong ML, Heistad DD. Functional improvement precedes structural regression of atherosclerosis. Circulation 1994;89:1810-8.
21. Gilmore JP. Neural control of extracellular volume in the human and nonhuman primate. In: Shepherd JT, Abboud FM, editors. Handbook of Physiology, Vol. III, Part 2. Baltimore (MD): American Physiological Society, 1983:885-915.
22. Souza SC, Frick GP, Wang X, Kopchick JJ, Lobo RB, Goodman MH. A single arginine residue determines species specificity of the human growth hormone receptor. Proc Natl Acad Sci USA 1995;92:959-63.
23. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 1984;54:711-8.
24. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-7.
25. Williams JK, Anthony MS, and Clarkson TB. Coronary heart disease in rhesus monkeys with diet-induced coronary artery atherosclerosis. Arch Pathol Lab Med 1991;115:784-90.
26. Hermsmeyer K, Kelley ST, Rösch J, Hall AS. Coronary artery vasospasm induced by combined serotonin and thromboxane stimulation in rhesus macaques [abstract]. Circulation 1994, 90 Suppl 1:1-258.
27. Berne RM. The role of adenosine in the regulation of the coronary blood flow. Circ Res 1980;47:807-13.
28. Fleming WW, Westfall DP, de la Lande IS, Jellett LB. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 1972;181:339-45.
29. Igarashi Y, Tamura Y, Tanabe Y, et al. Correlation between isolated negative U waves and the grade of coronary artery spasm. Jpn Circ J 1995;59:80-8.
30. Curry RC, Pepine CJ, Sabom MB, Conti CR. Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation 1979;59:307-12.
31. Egashira K, Tomoike H, Yamamoto Y, Yamada A, Hayashi Y, Nakamura M. Histamine-induced coronary spasm in regions of intimai thickening in miniature pigs: roles of serum cholesterol and spontaneous or induced intimai thickening. Circulation 1986;74:826-37.
32. van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation 1989;79:116-24.
33. Buja LM. Basic pathological processes of the heart: relationship to cardiomyopathies. In: Sperelakis N, editor. Physiology and Pathophysiology of the Heart. 3rd ed. Dordrecht (The Netherlands): Kluwer, 1995:37-53.
34. Henry PD, Yokoyama M. Supersensitivity of atherosclerotic rabbit aorta to ergonovine: mediation by a serotonergic mechanism. J Clin Invest 1980;66: 306-13.
35. Benedict CR, Mathew B, Rex KA, Cartwright JJ, Sordahl LA. Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res 1986;58: 58-67.
36. Armstrong ML. Atherosclerosis in rhesus cynomolgus monkeys. Primates Med 1976;9:16-40.
37. Faraci FM, Williams JK, Breese KR, Armstrong ML, Heistad DD. Atherosclerosis potentiates constrictor responses of cerebral and ocular vessels to thromboxane in monkeys. Stroke 1989;20:242-7.
38. Chilian WM, Dellsperger KC, Layne SM, et al. Effects of atherosclerosis on the coronary microcirculation. Am J Physiol 1990;258:H529-39.
39. Davis-Bruno KL, Halushka PV. Molecular pharmacology and therapeutic potential of thromboxane A, receptor antagonists. Adv Drug Res 1994;25: 173-202.
40. 2+ release mechanism of primate drug-induced coronary vasospasm. Am J Physiol. In press.
41. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and clinical implications. Circulation 1989;80:198-205.
42. Anderson HV, Kirdeeide RL, Krishnaswami A, et al. Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal anti-platelet antibody. J Am Coll Cardiol 1994;23:1031-7.
43. Hermsmeyer K, Erne P. Vascular muscle ion channels and cellular calcium regulation in hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York: Raven Press, 1995:673-83.